A lot of similarities in the trial wrap up timeline for BETonMACE compared to Amarin's REDUCE-IT trial:

Amarin:

April 4, 2018: Amarin announced that REDUCE-IT reached target1,612 MACE events and that top-line results are expected before the end of Q3 2018 (September 2018).

June 28, 2018: Amarin announced that the last patient study visit had occurred and reiterated that it anticipates having top-line results before the end of Q3 2018 (September 2018).

September 24th, 2018: Amarin announced top-line data.

November 10th, 2018: Amarin presents REDUCE-IT full data at AHA.

Resverlogix:

April 18, 2019: Resverlogix announced that has reached its target 250 MACE events.

July 8, 2019: Resverlogix announced that final patient safety follow up visits have occurred and that top-line results are expected by end of Q3 2019 (September 2019).

Top-line in September 2019 and full data at AHA 2019 would be consistent with Amarin's REDUCE-IT roll out.

BearDownAZ